Down syndrome

Also known as: 다운 증후군 21삼체성, trisomy 21, 몽고증

Pediatrics doctors

Doctors who treat Down syndrome

See all
Kangbuk Samsung Hospital Yang A-ram

Yang A-ram

Kangbuk Samsung Hospital · Pediatrics

1형 및 2형 당뇨 (인공췌장클리닉), 희귀유전질환 (Turner syndrome, Prader-Willi syndrome, 골이형성증 그외 유전대사질환-성인포함), 리소좀축적질환 (뮤코다당증, 고셔병, 폼페병), 내분비 질환 (성장/사춘기, 소아비만, 갑상선, 부신 및 뇌하수체질환 등)

5.0
Inha University Hospital Lee Ji-eun

Lee Ji-eun

Inha University Hospital · Pediatrics

소아유전대사, 내분비대사, 당뇨병, 비만, 성장이상(저신장,성조숙증), 염색체이상, 유전성희귀질환

5.0
Chungnam National University Hospital Lim Han-hyeok

Lim Han-hyeok

Chungnam National University Hospital · Pediatrics

내분비대사질환(당뇨병, 갑상선, 뇌하수체질환, 성분화이상, 비만), 성장이상(저신장, 성조숙증) 유전대사질환클리닉★ 심층진료★

5.0
Ewha Womans University Mokdong Hospital Park Eun-ae

Park Eun-ae

Ewha Womans University Mokdong Hospital · Pediatrics

미숙아·신생아질환(신생아황달, 호흡곤란 등), 미숙아 추적 관리, 선천 기형, 유전질환

5.0
Seoul National University Bundang Hospital Kim Jae-hyeon

Kim Jae-hyeon

Seoul National University Bundang Hospital · Pediatrics

소아청소년당뇨병, 대사증후군/비만, 고지혈증, 갑상샘질환, 부신질환, 뇌하수체질환, 성장장애, 사춘기질환

4.0
Seoul National University Bundang Hospital Kim Ji-hyeon

Kim Ji-hyeon

Seoul National University Bundang Hospital · Pediatrics

혈뇨, 단백뇨, 유전성 신질환, 알포트 증후군, 요로감염, 수신증, 선천성 신장 요로 기형, 만성 콩팥병, 급성 신손상, 자반증, 신장염, 신증후군, 야뇨증

4.0
Inha University Hospital Kim Su-jin

Kim Su-jin

Inha University Hospital · Pediatrics

유전성대사질환, 사춘기질환, 저신장, 당뇨병, 갑상선 내분비질환, 소아신장질환(혈뇨, 단백뇨, 신증후군, 급/만성 신부전, 선천성 신장질환)

Seoul National University Bundang Hospital Kim Hwa-yeong

Kim Hwa-yeong

Seoul National University Bundang Hospital · Pediatrics

소아청소년당뇨병, 대사증후군/비만, 고지혈증, 갑상샘질환, 부신질환, 뇌하수체질환, 성장장애, 사춘기질환, 희귀유전성질환, 선천성대사이상

Konyang University Hospital Oh Jun-seok

Oh Jun-seok

Konyang University Hospital · Pediatrics

성조숙증, 저신장, 당뇨, 비만, 갑상선 질환 등 소아내분비 질환, 희귀질환(극희귀질환 진단 의사)

Korea University Ansan Hospital Kang Eun-gu

Kang Eun-gu

Korea University Ansan Hospital · Pediatrics

유전, 대사내분비 클리닉

1) Disease Description (Causes and Symptoms)

  • Definition and causes
    • Diabetic retinopathy is a complication caused by damage to the retinal microvasculature due to diabetes. Pathophysiologically, hyperglycemia causes vascular endothelial damage, increased vascular permeability, microvascular occlusion (ischemia), and neovascularization (proliferation of new blood vessels).
    • The risk of occurrence is closely related to the duration of diabetes; in general, the longer a person has had diabetes, the higher the incidence (e.g., approximately 60–70% after around 15 years of disease and approximately 90% after more than 30 years).
  • Main symptoms
    • It is often asymptomatic in the early stages. Main symptoms include decreased vision, metamorphopsia, in which objects appear distorted due to central visual field (macular) impairment, blurred vision, floaters (floating spots or specks), photopsia, and partial visual field defects.
    • Complications may include macular edema (a major cause of decreased central vision), vitreous hemorrhage, tractional retinal detachment, and complications caused by neovascularization (neovascular bleeding and neovascular glaucoma).
  • Classification (brief)
    • Nonproliferative (early stage): microvascular damage, hemorrhage, mild ischemia, vascular leakage, etc.
    • Proliferative (advanced stage): neovascularization develops in ischemic areas, increasing the risk of hemorrhage and tractional retinal detachment

2) Treatment Methods and Precautions (Including Medications, Procedures, Surgery, and Lifestyle Management)

  • Systemic management (the foundation of treatment)
    • Blood glucose control: suppresses the occurrence and progression of the disease over the long term. The HbA1c target differs for each patient and should be determined with the attending physician.
    • Blood pressure and lipid control: actively treat coexisting hypertension and dyslipidemia to suppress worsening of retinopathy. Smoking cessation is recommended.
    • Because retinopathy may worsen during pregnancy, frequent examinations are necessary.
  • Local and ophthalmic treatment (standard treatment)
    • Macular edema (DME)
      • First-line: intravitreal anti-VEGF injections (e.g., ranibizumab, aflibercept, bevacizumab, including uninsured and off-label use) — effective for improving vision and reducing edema.
      • Steroids (intravitreal or implants): considered when there is no response to anti-VEGF or in special circumstances (adverse effects: increased intraocular pressure and progression of cataracts).
      • Laser (focal/grid photocoagulation): effective for certain cases of DME; although anti-VEGF is currently preferred, it may be used in combination or selected depending on the lesion pattern.
    • Proliferative diabetic retinopathy (PDR)
      • Panretinal photocoagulation (PRP): suppresses neovascularization and reduces the risk of blindness.
      • Anti-VEGF injections: may be used before or after PRP or as adjunctive treatment.
    • Surgical treatment
      • Vitrectomy and, when necessary, retinal surgery are performed for vitreous hemorrhage, tractional retinal detachment, or cases that cannot be resolved with photocoagulation.
  • Diagnostic tests (tests for treatment decisions)
    • Dilated fundus examination (including slit-lamp-assisted examination), fluorescein angiography (FA), optical coherence tomography (OCT), ultrasonography (B-scan), etc.
  • Precautions and adverse effects
    • Rapid improvement in blood glucose may temporarily worsen retinopathy; a plan should be established with a physician.
    • Adverse effects of laser treatment: visual field defects, decreased night vision, macular damage, etc.
    • Adverse effects of anti-VEGF injections: injection-related infection (endophthalmitis), temporary increase in intraocular pressure, etc.
    • Steroid use may cause increased intraocular pressure and progression of cataracts.
  • Prognosis
    • Early detection and treatment can greatly reduce the risk of blindness. The presence or absence of macular damage has a major impact on the visual prognosis.

3) Checkpoints Before an Outpatient Visit (Including Items to Bring, Preparation Before the Visit, and Example Questions)

  • Items to bring/materials that can be submitted
    • List of currently used medications (including oral medications, insulin, and anticoagulants)
    • Recent blood glucose/HbA1c test results and blood pressure/lipid test results (if possible, from the past 3–6 months)
    • Previous ophthalmic examination records (fundus photographs, OCT, fluorescein angiography results, etc.)
    • Record of changes in symptoms (when they began and what symptoms are present: blurring, floaters, photopsia, metamorphopsia, etc.)
    • Pregnancy status (for women) and smoking status
  • Symptoms to check before the visit (to be observed by the patient)
    • Immediate emergency medical care is necessary if sudden vision loss, numerous floaters (an increase in floating objects), flashes of light (photopsia), or partial loss of the visual field occurs.
  • Materials or notes to show the doctor during the outpatient visit
    • When symptoms began and how they have progressed, recent blood glucose control status, and history of previous ophthalmic treatment (laser treatment, injections, surgery, etc.)

4) Examples of General Questions to Ask the Doctor

  • "What stage is my retinopathy at? Is there an abnormality (edema) in the macula?"
  • "Do I currently need a procedure (laser treatment or anti-VEGF)? What are the advantages and disadvantages of each treatment?"
  • "What is my prognosis (the likelihood of preserving vision)? What should I be especially careful about in daily life?"
  • "What adverse effects or complications may occur after treatment, and how should I prepare for them?"

5) Examples of Disease-Specific Questions

  • "My recent HbA1c is [value]. Can progression of diabetic retinopathy be prevented with this level of control? What should my target HbA1c be?"
  • "My macular thickness on OCT was [value] μm. Do I need an anti-VEGF injection, or would laser treatment be more appropriate?"

(If necessary, if you provide your test results or recent blood glucose and medication information, we can organize more specific questions for consultation and a preparation checklist for your outpatient visit.)

Patient stories: Down syndrome

Talk with other Down syndrome patientsAsk people who have been through itWrite

Hospitals that treat Down syndrome

University hospitals where the doctors above see patients. Open a hospital to see its doctors by specialty and how to book.

Other conditions in Pediatrics

Condition guide
Find top doctors for 'Down syndrome'

Reviewed by · GoodDoctorNet medical specialists

This information is for general understanding only and does not replace diagnosis, prescription or treatment for an individual patient. If you have symptoms, please see a doctor.

Our medical content policy (in Korean) →